ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

ClinicalTrials.gov ID: NCT07351058

Public ClinicalTrials.gov record NCT07351058. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 27, 2026, 12:52 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Once-Weekly RO7795068 Administered to Participants With Obesity or Overweight and Type 2 Diabetes

Study identification

NCT ID
NCT07351058
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
1,600 participants

Conditions and interventions

Interventions

  • Enicepatide Combination Product
  • Placebo Combination Product

Combination Product

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 22, 2026
Primary completion
Aug 6, 2028
Completion
Aug 6, 2028
Last update posted
Apr 23, 2026

2026 – 2028

United States locations

U.S. sites
19
U.S. states
15
U.S. cities
19
Facility City State ZIP Site status
Lakeview Clinical Research Guntersville Alabama 35976 Recruiting
Arizona Clinical Trials Tucson Arizona 85711 Recruiting
Orange County Research Center Lake Forest California 92630 Recruiting
Ark Clinical Research Long Beach California 90815 Recruiting
Catalina Research Institute, LLC Montclair California 91763 Recruiting
Prospective Research Innovations Inc. Rancho Cucamonga California 91730 Recruiting
Emerson Clinical Research Institute Washington D.C. District of Columbia 20009 Recruiting
Progressive Medical Research Port Orange Florida 32127 Recruiting
Elevate Clinical Research Lake Charles Louisiana 70605 Recruiting
Centennial Medical Group Columbia Maryland 21045-5840 Recruiting
Centricity Research Morehead City Multispeciality Morehead City North Carolina 28557 Recruiting
Remington Davis Inc Columbus Ohio 43215 Recruiting
Essential Medical Research Tulsa Oklahoma 74137 Recruiting
Coastal Carolina Research Center North Charleston South Carolina 29405 Recruiting
Circle Clinical Research Sioux Falls South Dakota 57104 Recruiting
Velocity Clinical Research Dallas Texas 75230 Recruiting
Juno Research, LLC Houston Texas 77040 Recruiting
Manassas Clinical Research Center Manassas Virginia 20110 Recruiting
Era Health Research Redmond Washington 98052 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07351058, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 23, 2026 · Synced Apr 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07351058 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →